effect of type 2 diabetes mellitus (T2DM) as a comorbid factor on the morbidity rate and length of hospital stay (LoS) in patients undergoing cholecystectomy

Abstract

Background: Cholecystectomy is a gold standard approach for the treatment of cholelithiasis. The efficacy of this treatment varies considerably, with morbidity and hospital stay depending on the country and hospital. Objective: This study aims to determine the effect of diabetes mellitus as a comorbid factor on morbidity rate and length of stay following cholecystectomy at Dr. Ramelan Naval Hospital, Surabaya between June 2019 and September 2020. Materials and Methods: This study used a descriptive analytical design with a retrospective approach. The total sampling technique was employed to determine the number of samples required. A total of 201 cases of gallstone disease were observed at Dr. Ramelan Naval Hospital, Surabaya between June 2019 and September 2020. However, a sample of 146 cases met the inclusion and exclusion criteria. The secondary data were collected from the medical records of the patients. The data were analyzed using SPSS 25 (IBM, US). Results: The contingency coefficient test revealed a correlation between diabetes as a comorbid factor and disease incidence (p = 0.019). In addition, the results suggested a correlation between diabetes as a comorbid factor and length of hospital stay (p = 0.034). Conclusion: The findings indicated that comorbidities such as diabetes were associated with morbidity rate and length of hospital stay in patients undergoing cholecystectomy.